I.V. immunoglobulin therapy for infectious diseases
- 6 May 2010
- journal article
- review article
- Published by BMJ in Drug and Therapeutics Bulletin
- Vol. 48 (5), 57-60
- https://doi.org/10.1136/dtb.2009.07.0032
Abstract
Intravenous human normal immunoglobulin (IVIG) is used as replacement therapy for patients with immunoglobulin deficiency and also for a few other licensed indications. Scientific rationale suggests that IVIG might help as treatment for certain serious infectious diseases that carry a high risk of death and for which there are limited alternative treatments. However, there is a limited worldwide supply of IVIG1 and the treatment is expensive. Here we assess the evidence on the efficacy of IVIG in certain infectious diseases.Keywords
This publication has 30 references indexed in Scilit:
- The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic reviewInternational Journal of Infectious Diseases, 2009
- Immunoglobulin prophylaxis in hematological malignancies and hematopoietic stem cell transplantationCochrane Database of Systematic Reviews, 2008
- One in five mortality in non-menstrual toxic shock syndrome versus no mortality in menstrual cases in a balanced French series of 55 casesEuropean Journal of Clinical Microbiology & Infectious Diseases, 2007
- Immunoglobulins, vaccines or interferon for preventing cytomegalovirus disease in solid organ transplant recipientsCochrane Database of Systematic Reviews, 2007
- Neutralization of staphylococcal exotoxins in vitro by human-origin intravenous immunoglobulinJournal of Infection and Chemotherapy, 2007
- Intravenous immunoglobulin for preventing infection in preterm and/or low birth weight infantsPublished by Wiley ,2004
- Intravenous immunoglobulin for treating sepsis, severe sepsis and septic shockPublished by Wiley ,2002
- Treatment with intravenously administered gamma globulin of chronic relapsing colitis induced by Clostridium difficile toxinThe Journal of Pediatrics, 1991
- Toxic shock syndrome in scalded childrenBurns, 1990
- TOXIC-SHOCK SYNDROME ASSOCIATED WITH PHAGE-GROUP-I STAPHYLOCOCCIThe Lancet, 1978